Extended delivery of the antimitotic agent colchicine from thermoresponsive N-isopropylacrylamide-based copolymer films to human vascular smooth muscle cells

Journal of Biomedical Materials Research - Part A

Volumn 67, Issue 2, 2003, Pages 667-673

  Wilson, S J ^a   Gorelov, A V ^a   Rochev, Y A ^a   McGillicuddy, F ^a   Dawson, K A ^a   Gallagher, W M ^a   Keenan, A K ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Colchicine; Flexiperm; Human vascular smooth muscle cells; NiPAAm NtBAAm; Proliferation; Thermoresponsive copolymers

Indexed keywords

CELLS; MONOMERS; MUSCLE;

CELL VIABILITY; PROLIFERATION;

COPOLYMERS;

ACRYLAMIDE DERIVATIVE; ANTIMITOTIC AGENT; COLCHICINE; COPOLYMER; MONOMER; N TERT BUTYLACRYLAMIDE; POLY(N ISOPROPYLACRYLAMIDE); UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FILM; HEAT SENSITIVITY; HUMAN; HUMAN CELL; HYDROPHOBICITY; ROOM TEMPERATURE; SMOOTH MUSCLE FIBER; SUSTAINED RELEASE PREPARATION; THERMODYNAMICS; VASCULARIZATION;

EID: 0348014791     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.10137     Document Type: Article

References (19)

1. Di Mario C, Marsico F, Adamian M, Karvouni E, Albiero R, Colombo A. New recipes for in-stent restenosis: Cut, grate, roast, or sandwich the neointima? Heart 2000;84:471-475.
2. Gershlick AH. Treating atherosclerosis: Local drug delivery from laboratory studies to clinical trials. Atherosclerosis 2002;160:259-271.
3. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: Current status and future strategies. J Am Coll Cardiol 2002;39:183-193.
4. O'Keefe JH Jr, McCallister BD, Bateman TM, Kuhnlein DL, Ligon RW, Hartzler GO. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 199;219:1597-1600.
5. Mishaly D, Fishbein I, Moscovitz D, Golomb G. Site-specific delivery of colchicine in rat carotid artery model of restenosis. J Controlled Release 1997;45:65-73.
6. Bult H. Restenosis: A challenge for pharmacology. Trends Pharmacol Sci 2000;21:274-279.
7. Lewis AL, Tolhurst LA, Stratford PW. Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation. Biomaterials 2002;23:1697-1706.
8. Piskareva OA, Rochev YA, Gavriliuk BK, Gorelov AV, Golubeva TA, Dawson KA. Effect of thermoreverse polymer matrix and collagen on the growth of human fibroblasts. Biofizika 1999;44:281-283.
9. Gorelov AV, Duchesne A, Dawson KA. Phase separation in dilute solutions of poly (N-isopropylacrylamide). Physica 1997;240:443-452.
10. Taylor LD, Cerankowski LD. Preparation of films exhibiting a balanced temperature dependence to permeation by aqueous solutions - A study of lower consulate behaviour. J Polym Sci, Polym Chem Edn 1975;13:2551.
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and toxicity assays. J Immunol Meth 1983;65:55-63.
12. Rochev Y, Golubeva T, Gorelov A, Allen L, Gallagher WM, Selezneva L, Gavrilyuk B, Dawson K. Surface modification for controlled cell growth on co-polymers of N-isopropylacrylamide. Prog Colloid Polym Sci 2001;118:153-156.
13. Takigawa M, Takano T, Shirai E, Suzuki F. Cytoskeleton and differentiation: effects of cytochalasin B and colchicine on expression of the differentiated phenotype of rabbit costal chondrocytes in culture. Cell Differ 1984;14:197-204.
14. Doorty KB, Golubeva TA, Gorelov AV, Rochev YA, Allen LA, Dawson KA, Gallagher WM, Keenan AK. Poly(N-isopropylacrylamide) co-polymer films as potential vehicles for delivery of an antimitotic agent to vascular smooth muscle cells. Cardiovasc Pathol 2003;12:105-110.
15. Zakhireh B, Malech HL. The effect of colchicine and vinblastine on the chemotactic response of human monocytes. J Immunol 1980;125:2143-2153.
16. Ehrenfeld M, Levy M, Bar Eli M, Gallily R, Eliakim M. Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers. Br J Clin Pharmacol 1980;10:297-300.
17. Diegelmann RE, Peterkofsky B. Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive drugs. Proc Natl Acad Sci USA 1972;69:892-896.
18. Muller DW, Ellis SG, Topol EJ. Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions. J Am Coll Cardiol 1991;17:126B-131B.
19. Gradus-Pizlo I, Wilensky RL, March KL, Fineberg N, Michaels M, Sandusky GE, Hathaway DR. Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: Effects on restenosis and implications for catheter-based drug delivery. J Am Coll Cardiol 1995;26:1549-1557.